publication date: Dec. 1, 2017

NCI Director’s Report Sharpless lists initial priorities for NCI: Big Data, cell therapy, and more trials at the NIH Clinical Center

By Matthew Bin Han Ong

NCI needs to focus on developing a structured approach to Big Data initiatives to ensure optimal use of the institute’s limited resources, said NCI Director Norman “Ned” Sharpless at his first joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors.

Sharpless, who was sworn in Oct. 17 as the 15th NCI director, had embarked on a five-month “listening tour” since his appointment June 9 to familiarize himself with the institute’s operations (The Cancer Letter, June 16).

“I was able to start even some of the educational parts of it before I was sworn in, and I had a very long period before I was sworn in,” Sharpless said at the meeting Nov. 29. “So, I have really started to crystallize a few ideas that I will be relaying out more formally later. Particularly, I think one of the first opportunities to do this will be with the NCI staff at a town hall on December 11.”

In his wide-ranging remarks, Sharpless outlined the following priorities:

Increasing the number of inpatients at the NIH Clinical Center to “make it thrive and prosper,” … Continue reading Sharpless lists initial priorities for NCI: Big Data, cell therapy, and more trials at the NIH Clinical Center

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.